Edition:
United States

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

4.56USD
3:40pm EDT
Change (% chg)

$0.09 (+2.01%)
Prev Close
$4.47
Open
$4.42
Day's High
$4.62
Day's Low
$4.42
Volume
43,006
Avg. Vol
81,997
52-wk High
$12.22
52-wk Low
$2.93

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.42 December 25 Sep 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 1 1 1 1
(3) HOLD 5 5 5 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.38 2.38 2.38 2.38

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 8 5.12 7.60 0.00 12.57
Quarter Ending Dec-17 8 4.94 6.30 0.00 26.32
Year Ending Dec-17 8 22.50 26.40 12.41 92.81
Year Ending Dec-18 8 31.03 49.48 18.00 70.86
Earnings (per share)
Quarter Ending Sep-17 8 -0.42 -0.32 -0.56 -0.82
Quarter Ending Dec-17 8 -0.39 -0.32 -0.52 -0.42
Year Ending Dec-17 8 -1.79 -1.22 -2.38 -2.05
Year Ending Dec-18 8 -1.51 -0.64 -2.13 -2.79

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-17 4.85 6.20 1.34 27.68
Quarter Ending Mar-17 6.97 6.21 0.76 10.85
Quarter Ending Dec-16 8.89 6.22 2.67 30.01
Quarter Ending Sep-16 9.48 5.92 3.56 37.57
Quarter Ending Jun-16 8.09 6.66 1.43 17.62

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 5.12 5.12 5.12 8.14 12.57
Quarter Ending Dec-17 4.94 4.94 4.94 4.85 26.32
Year Ending Dec-17 22.50 22.50 22.50 23.67 92.81
Year Ending Dec-18 31.03 31.03 31.03 40.47 70.86

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-17 0 0 0 0
Quarter Ending Dec-17 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings